世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

経皮吸収型テープの世界市場規模、メーカー、サプライチェーン、販売チャネル、顧客、2022-2028年


Global Transdermal Patch Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

経皮吸収型パッチは、皮膚に貼付して、皮膚から血液中に特定量の薬を送り込む薬用粘着パッチです。経皮吸収型パッチには、フェンタニル経皮吸収型パッチ、ニコチン経皮吸収型パッチ、ブプレノルフィン経皮吸収型... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2022年9月5日 US$5,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

経皮吸収型パッチは、皮膚に貼付して、皮膚から血液中に特定量の薬を送り込む薬用粘着パッチです。経皮吸収型パッチには、フェンタニル経皮吸収型パッチ、ニコチン経皮吸収型パッチ、ブプレノルフィン経皮吸収型パッチ、クロニジン経皮吸収型パッチ、オキシブチニン経皮吸収型パッチ、エストラジオール経皮吸収型パッチ、ニトログリセリン経皮吸収型パッチなど多くのものが含まれています。

ハイライト
COVID-19やロシア・ウクライナ戦争の影響による経済変化を考慮すると、経皮パッチの世界市場は2023年から2028年の間にCAGR3.6%で、2022年の推定7058.3万米ドルから2028年には8726.9万米ドルに達すると予測されます。
経皮吸収型パッチは、主に以下のタイプに分類されます。サリチル酸メチル系パッチ、リバスチグミン系パッチ、フェンタニル系パッチ、リドカイン系パッチ、ジクロフェナク系パッチ、ニコチン系パッチ、その他に分類されます。サリチル酸メチル系が18%で市場の大部分を占め、リドカイン系が15%でこれに続いています。
経皮吸収型テープ製剤は、医療用医薬品と一般用医薬品の両方を通じて薬物を供給することができる。市場占有率は前者の方が高く、販売量は全体の約76%を占めている。
久光製薬、ジョンソン・エンド・ジョンソン、日東電工、マイランが世界経皮吸収パッチ市場のトップ4プレイヤーです。彼らは2019年に世界市場の約42％を占めた。

レポートの範囲
当レポートは、読者がビジネス/成長戦略の策定、市場競争状況の評価、現在の市場における自社のポジション分析、Transdermal Patchに関する情報に基づいたビジネス上の意思決定を行えるよう、定量・定性分析を交えてTransdermal Patchの世界市場を包括的に提示することを目的としています。
経皮吸収パッチの市場規模、推計、予測は、2021年を基準年とし、2017年から2028年までの期間の履歴と予測データを考慮して、販売量（M Pcs）および収益（百万ドル）で提供しています。本レポートでは、世界の経皮吸収型パッチ市場を包括的にセグメントしています。また、タイプ別、用途別、プレイヤー別の製品に関する地域別市場規模も掲載しています。市場規模を推定する際には、COVID-19とロシア・ウクライナ戦争の影響を考慮しました。
市場をより深く理解するために、競合環境、主要な競合他社のプロファイル、それぞれの市場ランクを提供しています。また、技術動向や新製品開発についても考察しています。
本レポートは、同市場の経皮吸収型パッチメーカー、新規参入企業、産業チェーン関連企業に対して、市場全体およびサブセグメントにおける企業別、製品タイプ別、用途別、地域別の収益、販売量、平均価格などの情報を提供するものである。

主要企業および市場シェアの洞察
本セクションでは、読者は競合する主要企業について理解を深めることができます。本レポートでは、革新的なトレンドと開発、製品ポートフォリオの強化、M&A、コラボレーション、新製品イノベーション、地域的拡大など、これらの参加企業がプレゼンスを維持するために行った主要な成長戦略を調査しています。事業戦略とは別に、本調査には現在の開発状況や主要財務情報も含まれています。読者はまた、期間2017-2022のメーカー別の世界収益、価格、売上高に関連するデータにアクセスすることができます。この包括的なレポートは、確かに更新を維持し、彼らのビジネスで効果的な意思決定を行うためにクライアントに役立つだろう。調査レポートでレビューされている著名なプレイヤーは以下の通りです。
久光製薬
ジョンソン・エンド・ジョンソン
ノバルティス
UCBファーマ
マイラン
テバ・ファーマシューティカル
日東電工
グリューネンタール
IBSAグループ
GSK
洛陽製薬グループ
ファイザー
チャテム
ドクター・レディーズ・ラボラトリーズ
バイエル
ムンディファーマ
遠藤インターナショナル
北京タイド製薬

製品タイプ別インサイト
経皮吸収型テープ製剤の世界市場をタイプ別に、2028年までの成長予測とともにお届けします。売上高と収益の推計は、経皮吸収型製剤がメーカーから調達されるサプライチェーンにおける価格に基づいています。
本レポートでは、各セグメントを調査し、過去のデータを用いて市場規模を提示しています。また、そのセグメントが将来もたらすかもしれない成長機会についても触れています。この研究は、タイプ別、および歴史的期間（2017-2022）と予測期間（2023-2028）の売上と収益のデータを授けるものです。
経皮吸収型パッチ タイプ別セグメント
サリチル酸メチル系パッチ
リバスチグミン系経皮吸収パッチ
フェンタニル経皮吸収パッチ
リドカインパッチ
ジクロフェナク貼付剤
ニコチン経皮吸収型テープ製剤
その他

アプリケーションインサイト
本レポートでは、過去期間（2017-2022年）および予測期間（2023-2028年）におけるアプリケーション別の市場規模（売上および収益データ）を掲載しています。
また、経皮吸収パッチ市場に影響を与える各分野の市場動向や消費者行動について概説し、これらが業界の将来にどのような示唆を与えるかについて解説しています。本レポートは、経皮吸収パッチ市場を牽引する関連市場および消費者動向の把握にお役立ていただけます。
経皮吸収パッチの用途別セグメント
Rxチャネル
OTCチャネル

地域別展望
本セクションでは、様々な地域と各地域で活動する主要企業に関する主要な洞察を提供します。特定の地域/国の成長を評価する際に、経済的、社会的、環境的、技術的、政治的な要因が考慮されています。読者はまた、2017年から2028年までの各地域と国の収益と売上データを手にすることができます。
市場は、北米、ヨーロッパ、アジア太平洋、南米、中東＆アフリカなど、さまざまな主要地域に区分されています。アメリカ、ドイツ、イギリス、イタリア、フランス、中国、日本、韓国、東南アジア、インドなどの主要国の詳細な分析は、地域セグメント内でカバーされる予定です。市場推定については、2021年を基準年としてデータを提供し、2022年の推定値と2028年の予測収益を提供する予定である。
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
ベネルクス
その他の欧州地域
アジア太平洋地域
中国
日本
韓国
インド
東南アジア
オーストラリア
その他のアジア太平洋地域
中南米
メキシコ
ブラジル
アルゼンチン
ラテンアメリカのその他
中近東・アフリカ
トルコ
サウジアラビア
UAE
その他の中東・アフリカ

主要なドライバーと障壁
本レポートでは、読者が一般的な開発を理解するのに役立つように、影響の大きいレンダリング要因とドライバーを調査しています。さらに、このレポートには、プレイヤーの道を阻むブロックとして機能する可能性のある抑制と課題も含まれています。これは、ユーザーが気を配り、ビジネスに関連する情報に基づいた意思決定を行うために支援します。専門家はまた、今後のビジネスの展望に彼らの焦点を置いています。
COVID-19とロシア・ウクライナ戦争影響力分析
このセクションの読者は、パンデミック、ポストパンデミック、ロシア-ウクライナ戦争の間に、経皮吸収パッチ市場のシナリオが世界中でどのように変化したかを理解することができます。この研究は、需要、消費、輸送、消費者行動、サプライチェーン管理、輸出入、生産などの側面の変化を視野に入れながら行われます。また、業界の専門家は、今後数年間でプレイヤーに機会を創出し、業界全体を安定させるのに役立つ主要な要因を取り上げています。

本レポートを購入する理由
本レポートは、読者が産業内の競争と、潜在的な利益を高めるための競争環境に対する戦略を理解するのに役立ちます。また、世界の経皮吸収型パッチ市場の競争環境に焦点を当て、主要企業の市場シェア、産業ランキング、競合のエコシステム、市場実績、新製品開発、経営状況、拡張、買収などを詳細に紹介し、読者が主要競合企業を特定し、市場の競争パターンを深く理解できるよう支援します。
本レポートは、関係者が経皮吸収パッチの世界的な産業状況と動向を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。
本レポートは、利害関係者が競合他社をより良く理解し、ビジネスにおける自社の地位を強化するためのより多くの洞察を得るのに役立ちます。競争環境のセクションでは、市場シェアと順位（数量と金額）、競合のエコシステム、新製品開発、拡大、買収を含みます。
本レポートは、新規技術の統合、機能、市場の最新動向について常に更新しています。
本レポートは、関係者がCOVID-19とロシア・ウクライナ戦争が経皮吸収パッチ産業に及ぼす影響を理解するのに役立ちます。
本レポートは、利害関係者が世界的にどの地域をターゲットとすべきかを洞察するのに役立ちます。
本レポートは、利害関係者が経皮吸収型製剤の採用に関するエンドユーザーの認識について洞察するのに役立ちます。
本レポートは、利害関係者が市場の主要プレイヤーを特定し、その貴重な貢献度を理解するのに役立ちます。


ページTOPに戻る


目次

1 Study Coverage
1.1 Transdermal Patch Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Patch Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Market by Application
1.3.1 Global Transdermal Patch Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transdermal Patch Market Size Estimates and Forecasts
2.1.1 Global Transdermal Patch Revenue 2017-2028
2.1.2 Global Transdermal Patch Sales 2017-2028
2.2 Transdermal Patch Market Size by Region: 2022 Versus 2028
2.3 Transdermal Patch Sales by Region (2017-2028)
2.3.1 Global Transdermal Patch Sales by Region: 2017-2022
2.3.2 Global Transdermal Patch Sales Forecast by Region (2023-2028)
2.3.3 Global Transdermal Patch Sales Market Share by Region (2017-2028)
2.4 Transdermal Patch Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Transdermal Patch Revenue by Region: 2017-2022
2.4.2 Global Transdermal Patch Revenue Forecast by Region (2023-2028)
2.4.3 Global Transdermal Patch Revenue Market Share by Region (2017-2028)
3 Global Transdermal Patch by Manufacturers
3.1 Global Top Transdermal Patch Manufacturers by Sales
3.1.1 Global Transdermal Patch Sales by Manufacturer (2017-2022)
3.1.2 Global Transdermal Patch Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Transdermal Patch Manufacturers by Revenue
3.2.1 Global Transdermal Patch Revenue by Manufacturer (2017-2022)
3.2.2 Global Transdermal Patch Revenue Share by Manufacturer (2017-2022)
3.3 Global Transdermal Patch Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Transdermal Patch Manufacturers Covered: Ranking by Revenue
3.4.2 Global Transdermal Patch Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Transdermal Patch Manufacturing Base Distribution, Product Type
3.5.1 Transdermal Patch Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Transdermal Patch Product Type
3.5.3 Date of International Manufacturers Enter into Transdermal Patch Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Hisamitsu Pharmaceutical
4.1.1 Hisamitsu Pharmaceutical Corporation Information
4.1.2 Hisamitsu Pharmaceutical Description, Business Overview
4.1.3 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
4.1.4 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Hisamitsu Pharmaceutical Transdermal Patch Sales by Product in 2021
4.1.6 Hisamitsu Pharmaceutical Transdermal Patch Sales by Application in 2021
4.1.7 Hisamitsu Pharmaceutical Transdermal Patch Sales by Geographic Area in 2021
4.1.8 Hisamitsu Pharmaceutical Recent Developments
4.2 Johnson & Johnson
4.2.1 Johnson & Johnson Corporation Information
4.2.2 Johnson & Johnson Description, Business Overview
4.2.3 Johnson & Johnson Transdermal Patch Products Offered
4.2.4 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Johnson & Johnson Transdermal Patch Sales by Product in 2021
4.2.6 Johnson & Johnson Transdermal Patch Sales by Application in 2021
4.2.7 Johnson & Johnson Transdermal Patch Sales by Geographic Area in 2021
4.2.8 Johnson & Johnson Recent Developments
4.3 Novartis
4.3.1 Novartis Corporation Information
4.3.2 Novartis Description, Business Overview
4.3.3 Novartis Transdermal Patch Products Offered
4.3.4 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Novartis Transdermal Patch Sales by Product in 2021
4.3.6 Novartis Transdermal Patch Sales by Application in 2021
4.3.7 Novartis Transdermal Patch Sales by Geographic Area in 2021
4.3.8 Novartis Recent Developments
4.4 UCB Pharma
4.4.1 UCB Pharma Corporation Information
4.4.2 UCB Pharma Description, Business Overview
4.4.3 UCB Pharma Transdermal Patch Products Offered
4.4.4 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.4.5 UCB Pharma Transdermal Patch Sales by Product in 2021
4.4.6 UCB Pharma Transdermal Patch Sales by Application in 2021
4.4.7 UCB Pharma Transdermal Patch Sales by Geographic Area in 2021
4.4.8 UCB Pharma Recent Developments
4.5 Mylan
4.5.1 Mylan Corporation Information
4.5.2 Mylan Description, Business Overview
4.5.3 Mylan Transdermal Patch Products Offered
4.5.4 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Mylan Transdermal Patch Sales by Product in 2021
4.5.6 Mylan Transdermal Patch Sales by Application in 2021
4.5.7 Mylan Transdermal Patch Sales by Geographic Area in 2021
4.5.8 Mylan Recent Developments
4.6 Teva Pharmaceutical
4.6.1 Teva Pharmaceutical Corporation Information
4.6.2 Teva Pharmaceutical Description, Business Overview
4.6.3 Teva Pharmaceutical Transdermal Patch Products Offered
4.6.4 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Teva Pharmaceutical Transdermal Patch Sales by Product in 2021
4.6.6 Teva Pharmaceutical Transdermal Patch Sales by Application in 2021
4.6.7 Teva Pharmaceutical Transdermal Patch Sales by Geographic Area in 2021
4.6.8 Teva Pharmaceutical Recent Development
4.7 Nitto Denko
4.7.1 Nitto Denko Corporation Information
4.7.2 Nitto Denko Description, Business Overview
4.7.3 Nitto Denko Transdermal Patch Products Offered
4.7.4 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Nitto Denko Transdermal Patch Sales by Product in 2021
4.7.6 Nitto Denko Transdermal Patch Sales by Application in 2021
4.7.7 Nitto Denko Transdermal Patch Sales by Geographic Area in 2021
4.7.8 Nitto Denko Recent Development
4.8 Grünenthal
4.8.1 Grünenthal Corporation Information
4.8.2 Grünenthal Description, Business Overview
4.8.3 Grünenthal Transdermal Patch Products Offered
4.8.4 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Grünenthal Transdermal Patch Sales by Product in 2021
4.8.6 Grünenthal Transdermal Patch Sales by Application in 2021
4.8.7 Grünenthal Transdermal Patch Sales by Geographic Area in 2021
4.8.8 Grünenthal Recent Development
4.9 IBSA Group
4.9.1 IBSA Group Corporation Information
4.9.2 IBSA Group Description, Business Overview
4.9.3 IBSA Group Transdermal Patch Products Offered
4.9.4 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.9.5 IBSA Group Transdermal Patch Sales by Product in 2021
4.9.6 IBSA Group Transdermal Patch Sales by Application in 2021
4.9.7 IBSA Group Transdermal Patch Sales by Geographic Area in 2021
4.9.8 IBSA Group Recent Development
4.10 GSK
4.10.1 GSK Corporation Information
4.10.2 GSK Description, Business Overview
4.10.3 GSK Transdermal Patch Products Offered
4.10.4 GSK Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.10.5 GSK Transdermal Patch Sales by Product in 2021
4.10.6 GSK Transdermal Patch Sales by Application in 2021
4.10.7 GSK Transdermal Patch Sales by Geographic Area in 2021
4.10.8 GSK Recent Development
4.11 Luye Pharma Group
4.11.1 Luye Pharma Group Corporation Information
4.11.2 Luye Pharma Group Description, Business Overview
4.11.3 Luye Pharma Group Transdermal Patch Products Offered
4.11.4 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Luye Pharma Group Transdermal Patch Sales by Product in 2021
4.11.6 Luye Pharma Group Transdermal Patch Sales by Application in 2021
4.11.7 Luye Pharma Group Transdermal Patch Sales by Geographic Area in 2021
4.11.8 Luye Pharma Group Recent Development
4.12 Pfizer
4.12.1 Pfizer Corporation Information
4.12.2 Pfizer Description, Business Overview
4.12.3 Pfizer Transdermal Patch Products Offered
4.12.4 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Pfizer Transdermal Patch Sales by Product in 2021
4.12.6 Pfizer Transdermal Patch Sales by Application in 2021
4.12.7 Pfizer Transdermal Patch Sales by Geographic Area in 2021
4.12.8 Pfizer Recent Development
4.13 Chattem
4.13.1 Chattem Corporation Information
4.13.2 Chattem Description, Business Overview
4.13.3 Chattem Transdermal Patch Products Offered
4.13.4 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Chattem Transdermal Patch Sales by Product in 2021
4.13.6 Chattem Transdermal Patch Sales by Application in 2021
4.13.7 Chattem Transdermal Patch Sales by Geographic Area in 2021
4.13.8 Chattem Recent Development
4.14 Dr Reddy’s Laboratories
4.14.1 Dr Reddy’s Laboratories Corporation Information
4.14.2 Dr Reddy’s Laboratories Description, Business Overview
4.14.3 Dr Reddy’s Laboratories Transdermal Patch Products Offered
4.14.4 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.14.5 Dr Reddy’s Laboratories Transdermal Patch Sales by Product in 2021
4.14.6 Dr Reddy’s Laboratories Transdermal Patch Sales by Application in 2021
4.14.7 Dr Reddy’s Laboratories Transdermal Patch Sales by Geographic Area in 2021
4.14.8 Dr Reddy’s Laboratories Recent Development
4.15 Bayer
4.15.1 Bayer Corporation Information
4.15.2 Bayer Description, Business Overview
4.15.3 Bayer Transdermal Patch Products Offered
4.15.4 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.15.5 Bayer Transdermal Patch Sales by Product in 2021
4.15.6 Bayer Transdermal Patch Sales by Application in 2021
4.15.7 Bayer Transdermal Patch Sales by Geographic Area in 2021
4.15.8 Bayer Recent Development
4.16 Mundipharma
4.16.1 Mundipharma Corporation Information
4.16.2 Mundipharma Description, Business Overview
4.16.3 Mundipharma Transdermal Patch Products Offered
4.16.4 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.16.5 Mundipharma Transdermal Patch Sales by Product in 2021
4.16.6 Mundipharma Transdermal Patch Sales by Application in 2021
4.16.7 Mundipharma Transdermal Patch Sales by Geographic Area in 2021
4.16.8 Mundipharma Recent Development
4.17 Endo International
4.17.1 Endo International Corporation Information
4.17.2 Endo International Description, Business Overview
4.17.3 Endo International Transdermal Patch Products Offered
4.17.4 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.17.5 Endo International Transdermal Patch Sales by Product in 2021
4.17.6 Endo International Transdermal Patch Sales by Application in 2021
4.17.7 Endo International Transdermal Patch Sales by Geographic Area in 2021
4.17.8 Endo International Recent Development
4.18 Beijing Tide Pharmaceutical
4.18.1 Beijing Tide Pharmaceutical Corporation Information
4.18.2 Beijing Tide Pharmaceutical Description, Business Overview
4.18.3 Beijing Tide Pharmaceutical Transdermal Patch Products Offered
4.18.4 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.18.5 Beijing Tide Pharmaceutical Transdermal Patch Sales by Product in 2021
4.18.6 Beijing Tide Pharmaceutical Transdermal Patch Sales by Application in 2021
4.18.7 Beijing Tide Pharmaceutical Transdermal Patch Sales by Geographic Area in 2021
4.18.8 Beijing Tide Pharmaceutical Recent Development
5 Breakdown Data by Type
5.1 Global Transdermal Patch Sales by Type (2017-2028)
5.1.1 Global Transdermal Patch Sales by Type (2017-2022)
5.1.2 Global Transdermal Patch Sales Forecast by Type (2023-2028)
5.1.3 Global Transdermal Patch Sales Market Share by Type (2017-2028)
5.2 Global Transdermal Patch Revenue Forecast by Type (2017-2028)
5.2.1 Global Transdermal Patch Revenue by Type (2017-2022)
5.2.2 Global Transdermal Patch Revenue Forecast by Type (2023-2028)
5.2.3 Global Transdermal Patch Revenue Market Share by Type (2017-2028)
5.3 Transdermal Patch Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Transdermal Patch Sales by Application (2017-2028)
6.1.1 Global Transdermal Patch Sales by Application (2017-2022)
6.1.2 Global Transdermal Patch Sales Forecast by Application (2023-2028)
6.1.3 Global Transdermal Patch Sales Market Share by Application (2017-2028)
6.2 Global Transdermal Patch Revenue Forecast by Application (2017-2028)
6.2.1 Global Transdermal Patch Revenue by Application (2017-2022)
6.2.2 Global Transdermal Patch Revenue Forecast by Application (2023-2028)
6.2.3 Global Transdermal Patch Revenue Market Share by Application (2017-2028)
6.3 Transdermal Patch Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Transdermal Patch Market Size YoY Growth 2017-2028
7.2 North America Transdermal Patch Market Facts & Figures by Country
7.2.1 North America Transdermal Patch Sales by Country (2017-2028)
7.2.2 North America Transdermal Patch Revenue by Country (2017-2028)
7.3 North America Transdermal Patch Sales by Type
7.4 North America Transdermal Patch Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Patch Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Transdermal Patch Market Facts & Figures by Region
8.2.1 Asia-Pacific Transdermal Patch Sales by Region (2017-2028)
8.2.2 Asia-Pacific Transdermal Patch Revenue by Region (2017-2028)
8.3 Asia-Pacific Transdermal Patch Sales by Type
8.4 Asia-Pacific Transdermal Patch Sales by Application
9 Europe
9.1 Europe Transdermal Patch Market Size YoY Growth 2017-2028
9.2 Europe Transdermal Patch Market Facts & Figures by Country
9.2.1 Europe Transdermal Patch Sales by Country (2017-2028)
9.2.2 Europe Transdermal Patch Revenue by Country (2017-2028)
9.3 Europe Transdermal Patch Sales by Type
9.4 Europe Transdermal Patch Sales by Application
10 Latin America
10.1 Latin America Transdermal Patch Market Size YoY Growth 2017-2028
10.2 Latin America Transdermal Patch Market Facts & Figures by Country
10.2.1 Latin America Transdermal Patch Sales by Country (2017-2028)
10.2.2 Latin America Transdermal Patch Revenue by Country (2017-2028)
10.3 Latin America Transdermal Patch Sales by Type
10.4 Latin America Transdermal Patch Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Transdermal Patch Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Transdermal Patch Market Facts & Figures by Country
11.2.1 Middle East and Africa Transdermal Patch Sales by Country (2017-2028)
11.2.2 Middle East and Africa Transdermal Patch Revenue by Country (2017-2028)
11.3 Middle East and Africa Transdermal Patch Sales by Type
11.4 Middle East and Africa Transdermal Patch Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Transdermal Patch Supply Chain Analysis
12.2 Transdermal Patch Key Raw Materials and Upstream Suppliers
12.3 Transdermal Patch Clients Analysis
12.4 Transdermal Patch Sales Channel and Sales Model Analysis
12.4.1 Transdermal Patch Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Transdermal Patch Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Transdermal Patch Distributors
13 Market Dynamics
13.1 Transdermal Patch Industry Trends
13.2 Transdermal Patch Market Drivers
13.3 Transdermal Patch Market Challenges
13.4 Transdermal Patch Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る


　

Summary

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Highlights
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Transdermal Patch market is projected to reach US$ 8726.9 million by 2028 from an estimated US$ 7058.3 million in 2022, at a CAGR of 3.6% during 2023 and 2028.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Transdermal Patch.
The Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Transdermal Patch market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical

Product Type Insights
Global markets are presented by Transdermal Patch type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Transdermal Patch are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Transdermal Patch Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Transdermal Patch market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Transdermal Patch market.
Transdermal Patch Segment by Application
Rx Channel
OTC Channel

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Transdermal Patch market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Transdermal Patch industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Transdermal Patch Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Patch Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Market by Application
1.3.1 Global Transdermal Patch Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transdermal Patch Market Size Estimates and Forecasts
2.1.1 Global Transdermal Patch Revenue 2017-2028
2.1.2 Global Transdermal Patch Sales 2017-2028
2.2 Transdermal Patch Market Size by Region: 2022 Versus 2028
2.3 Transdermal Patch Sales by Region (2017-2028)
2.3.1 Global Transdermal Patch Sales by Region: 2017-2022
2.3.2 Global Transdermal Patch Sales Forecast by Region (2023-2028)
2.3.3 Global Transdermal Patch Sales Market Share by Region (2017-2028)
2.4 Transdermal Patch Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Transdermal Patch Revenue by Region: 2017-2022
2.4.2 Global Transdermal Patch Revenue Forecast by Region (2023-2028)
2.4.3 Global Transdermal Patch Revenue Market Share by Region (2017-2028)
3 Global Transdermal Patch by Manufacturers
3.1 Global Top Transdermal Patch Manufacturers by Sales
3.1.1 Global Transdermal Patch Sales by Manufacturer (2017-2022)
3.1.2 Global Transdermal Patch Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Transdermal Patch Manufacturers by Revenue
3.2.1 Global Transdermal Patch Revenue by Manufacturer (2017-2022)
3.2.2 Global Transdermal Patch Revenue Share by Manufacturer (2017-2022)
3.3 Global Transdermal Patch Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Transdermal Patch Manufacturers Covered: Ranking by Revenue
3.4.2 Global Transdermal Patch Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Transdermal Patch Manufacturing Base Distribution, Product Type
3.5.1 Transdermal Patch Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Transdermal Patch Product Type
3.5.3 Date of International Manufacturers Enter into Transdermal Patch Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Hisamitsu Pharmaceutical
4.1.1 Hisamitsu Pharmaceutical Corporation Information
4.1.2 Hisamitsu Pharmaceutical Description, Business Overview
4.1.3 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
4.1.4 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Hisamitsu Pharmaceutical Transdermal Patch Sales by Product in 2021
4.1.6 Hisamitsu Pharmaceutical Transdermal Patch Sales by Application in 2021
4.1.7 Hisamitsu Pharmaceutical Transdermal Patch Sales by Geographic Area in 2021
4.1.8 Hisamitsu Pharmaceutical Recent Developments
4.2 Johnson & Johnson
4.2.1 Johnson & Johnson Corporation Information
4.2.2 Johnson & Johnson Description, Business Overview
4.2.3 Johnson & Johnson Transdermal Patch Products Offered
4.2.4 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Johnson & Johnson Transdermal Patch Sales by Product in 2021
4.2.6 Johnson & Johnson Transdermal Patch Sales by Application in 2021
4.2.7 Johnson & Johnson Transdermal Patch Sales by Geographic Area in 2021
4.2.8 Johnson & Johnson Recent Developments
4.3 Novartis
4.3.1 Novartis Corporation Information
4.3.2 Novartis Description, Business Overview
4.3.3 Novartis Transdermal Patch Products Offered
4.3.4 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Novartis Transdermal Patch Sales by Product in 2021
4.3.6 Novartis Transdermal Patch Sales by Application in 2021
4.3.7 Novartis Transdermal Patch Sales by Geographic Area in 2021
4.3.8 Novartis Recent Developments
4.4 UCB Pharma
4.4.1 UCB Pharma Corporation Information
4.4.2 UCB Pharma Description, Business Overview
4.4.3 UCB Pharma Transdermal Patch Products Offered
4.4.4 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.4.5 UCB Pharma Transdermal Patch Sales by Product in 2021
4.4.6 UCB Pharma Transdermal Patch Sales by Application in 2021
4.4.7 UCB Pharma Transdermal Patch Sales by Geographic Area in 2021
4.4.8 UCB Pharma Recent Developments
4.5 Mylan
4.5.1 Mylan Corporation Information
4.5.2 Mylan Description, Business Overview
4.5.3 Mylan Transdermal Patch Products Offered
4.5.4 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Mylan Transdermal Patch Sales by Product in 2021
4.5.6 Mylan Transdermal Patch Sales by Application in 2021
4.5.7 Mylan Transdermal Patch Sales by Geographic Area in 2021
4.5.8 Mylan Recent Developments
4.6 Teva Pharmaceutical
4.6.1 Teva Pharmaceutical Corporation Information
4.6.2 Teva Pharmaceutical Description, Business Overview
4.6.3 Teva Pharmaceutical Transdermal Patch Products Offered
4.6.4 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Teva Pharmaceutical Transdermal Patch Sales by Product in 2021
4.6.6 Teva Pharmaceutical Transdermal Patch Sales by Application in 2021
4.6.7 Teva Pharmaceutical Transdermal Patch Sales by Geographic Area in 2021
4.6.8 Teva Pharmaceutical Recent Development
4.7 Nitto Denko
4.7.1 Nitto Denko Corporation Information
4.7.2 Nitto Denko Description, Business Overview
4.7.3 Nitto Denko Transdermal Patch Products Offered
4.7.4 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Nitto Denko Transdermal Patch Sales by Product in 2021
4.7.6 Nitto Denko Transdermal Patch Sales by Application in 2021
4.7.7 Nitto Denko Transdermal Patch Sales by Geographic Area in 2021
4.7.8 Nitto Denko Recent Development
4.8 Grünenthal
4.8.1 Grünenthal Corporation Information
4.8.2 Grünenthal Description, Business Overview
4.8.3 Grünenthal Transdermal Patch Products Offered
4.8.4 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Grünenthal Transdermal Patch Sales by Product in 2021
4.8.6 Grünenthal Transdermal Patch Sales by Application in 2021
4.8.7 Grünenthal Transdermal Patch Sales by Geographic Area in 2021
4.8.8 Grünenthal Recent Development
4.9 IBSA Group
4.9.1 IBSA Group Corporation Information
4.9.2 IBSA Group Description, Business Overview
4.9.3 IBSA Group Transdermal Patch Products Offered
4.9.4 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.9.5 IBSA Group Transdermal Patch Sales by Product in 2021
4.9.6 IBSA Group Transdermal Patch Sales by Application in 2021
4.9.7 IBSA Group Transdermal Patch Sales by Geographic Area in 2021
4.9.8 IBSA Group Recent Development
4.10 GSK
4.10.1 GSK Corporation Information
4.10.2 GSK Description, Business Overview
4.10.3 GSK Transdermal Patch Products Offered
4.10.4 GSK Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.10.5 GSK Transdermal Patch Sales by Product in 2021
4.10.6 GSK Transdermal Patch Sales by Application in 2021
4.10.7 GSK Transdermal Patch Sales by Geographic Area in 2021
4.10.8 GSK Recent Development
4.11 Luye Pharma Group
4.11.1 Luye Pharma Group Corporation Information
4.11.2 Luye Pharma Group Description, Business Overview
4.11.3 Luye Pharma Group Transdermal Patch Products Offered
4.11.4 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Luye Pharma Group Transdermal Patch Sales by Product in 2021
4.11.6 Luye Pharma Group Transdermal Patch Sales by Application in 2021
4.11.7 Luye Pharma Group Transdermal Patch Sales by Geographic Area in 2021
4.11.8 Luye Pharma Group Recent Development
4.12 Pfizer
4.12.1 Pfizer Corporation Information
4.12.2 Pfizer Description, Business Overview
4.12.3 Pfizer Transdermal Patch Products Offered
4.12.4 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Pfizer Transdermal Patch Sales by Product in 2021
4.12.6 Pfizer Transdermal Patch Sales by Application in 2021
4.12.7 Pfizer Transdermal Patch Sales by Geographic Area in 2021
4.12.8 Pfizer Recent Development
4.13 Chattem
4.13.1 Chattem Corporation Information
4.13.2 Chattem Description, Business Overview
4.13.3 Chattem Transdermal Patch Products Offered
4.13.4 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Chattem Transdermal Patch Sales by Product in 2021
4.13.6 Chattem Transdermal Patch Sales by Application in 2021
4.13.7 Chattem Transdermal Patch Sales by Geographic Area in 2021
4.13.8 Chattem Recent Development
4.14 Dr Reddy’s Laboratories
4.14.1 Dr Reddy’s Laboratories Corporation Information
4.14.2 Dr Reddy’s Laboratories Description, Business Overview
4.14.3 Dr Reddy’s Laboratories Transdermal Patch Products Offered
4.14.4 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.14.5 Dr Reddy’s Laboratories Transdermal Patch Sales by Product in 2021
4.14.6 Dr Reddy’s Laboratories Transdermal Patch Sales by Application in 2021
4.14.7 Dr Reddy’s Laboratories Transdermal Patch Sales by Geographic Area in 2021
4.14.8 Dr Reddy’s Laboratories Recent Development
4.15 Bayer
4.15.1 Bayer Corporation Information
4.15.2 Bayer Description, Business Overview
4.15.3 Bayer Transdermal Patch Products Offered
4.15.4 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.15.5 Bayer Transdermal Patch Sales by Product in 2021
4.15.6 Bayer Transdermal Patch Sales by Application in 2021
4.15.7 Bayer Transdermal Patch Sales by Geographic Area in 2021
4.15.8 Bayer Recent Development
4.16 Mundipharma
4.16.1 Mundipharma Corporation Information
4.16.2 Mundipharma Description, Business Overview
4.16.3 Mundipharma Transdermal Patch Products Offered
4.16.4 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.16.5 Mundipharma Transdermal Patch Sales by Product in 2021
4.16.6 Mundipharma Transdermal Patch Sales by Application in 2021
4.16.7 Mundipharma Transdermal Patch Sales by Geographic Area in 2021
4.16.8 Mundipharma Recent Development
4.17 Endo International
4.17.1 Endo International Corporation Information
4.17.2 Endo International Description, Business Overview
4.17.3 Endo International Transdermal Patch Products Offered
4.17.4 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.17.5 Endo International Transdermal Patch Sales by Product in 2021
4.17.6 Endo International Transdermal Patch Sales by Application in 2021
4.17.7 Endo International Transdermal Patch Sales by Geographic Area in 2021
4.17.8 Endo International Recent Development
4.18 Beijing Tide Pharmaceutical
4.18.1 Beijing Tide Pharmaceutical Corporation Information
4.18.2 Beijing Tide Pharmaceutical Description, Business Overview
4.18.3 Beijing Tide Pharmaceutical Transdermal Patch Products Offered
4.18.4 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2017-2022)
4.18.5 Beijing Tide Pharmaceutical Transdermal Patch Sales by Product in 2021
4.18.6 Beijing Tide Pharmaceutical Transdermal Patch Sales by Application in 2021
4.18.7 Beijing Tide Pharmaceutical Transdermal Patch Sales by Geographic Area in 2021
4.18.8 Beijing Tide Pharmaceutical Recent Development
5 Breakdown Data by Type
5.1 Global Transdermal Patch Sales by Type (2017-2028)
5.1.1 Global Transdermal Patch Sales by Type (2017-2022)
5.1.2 Global Transdermal Patch Sales Forecast by Type (2023-2028)
5.1.3 Global Transdermal Patch Sales Market Share by Type (2017-2028)
5.2 Global Transdermal Patch Revenue Forecast by Type (2017-2028)
5.2.1 Global Transdermal Patch Revenue by Type (2017-2022)
5.2.2 Global Transdermal Patch Revenue Forecast by Type (2023-2028)
5.2.3 Global Transdermal Patch Revenue Market Share by Type (2017-2028)
5.3 Transdermal Patch Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Transdermal Patch Sales by Application (2017-2028)
6.1.1 Global Transdermal Patch Sales by Application (2017-2022)
6.1.2 Global Transdermal Patch Sales Forecast by Application (2023-2028)
6.1.3 Global Transdermal Patch Sales Market Share by Application (2017-2028)
6.2 Global Transdermal Patch Revenue Forecast by Application (2017-2028)
6.2.1 Global Transdermal Patch Revenue by Application (2017-2022)
6.2.2 Global Transdermal Patch Revenue Forecast by Application (2023-2028)
6.2.3 Global Transdermal Patch Revenue Market Share by Application (2017-2028)
6.3 Transdermal Patch Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Transdermal Patch Market Size YoY Growth 2017-2028
7.2 North America Transdermal Patch Market Facts & Figures by Country
7.2.1 North America Transdermal Patch Sales by Country (2017-2028)
7.2.2 North America Transdermal Patch Revenue by Country (2017-2028)
7.3 North America Transdermal Patch Sales by Type
7.4 North America Transdermal Patch Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Patch Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Transdermal Patch Market Facts & Figures by Region
8.2.1 Asia-Pacific Transdermal Patch Sales by Region (2017-2028)
8.2.2 Asia-Pacific Transdermal Patch Revenue by Region (2017-2028)
8.3 Asia-Pacific Transdermal Patch Sales by Type
8.4 Asia-Pacific Transdermal Patch Sales by Application
9 Europe
9.1 Europe Transdermal Patch Market Size YoY Growth 2017-2028
9.2 Europe Transdermal Patch Market Facts & Figures by Country
9.2.1 Europe Transdermal Patch Sales by Country (2017-2028)
9.2.2 Europe Transdermal Patch Revenue by Country (2017-2028)
9.3 Europe Transdermal Patch Sales by Type
9.4 Europe Transdermal Patch Sales by Application
10 Latin America
10.1 Latin America Transdermal Patch Market Size YoY Growth 2017-2028
10.2 Latin America Transdermal Patch Market Facts & Figures by Country
10.2.1 Latin America Transdermal Patch Sales by Country (2017-2028)
10.2.2 Latin America Transdermal Patch Revenue by Country (2017-2028)
10.3 Latin America Transdermal Patch Sales by Type
10.4 Latin America Transdermal Patch Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Transdermal Patch Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Transdermal Patch Market Facts & Figures by Country
11.2.1 Middle East and Africa Transdermal Patch Sales by Country (2017-2028)
11.2.2 Middle East and Africa Transdermal Patch Revenue by Country (2017-2028)
11.3 Middle East and Africa Transdermal Patch Sales by Type
11.4 Middle East and Africa Transdermal Patch Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Transdermal Patch Supply Chain Analysis
12.2 Transdermal Patch Key Raw Materials and Upstream Suppliers
12.3 Transdermal Patch Clients Analysis
12.4 Transdermal Patch Sales Channel and Sales Model Analysis
12.4.1 Transdermal Patch Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Transdermal Patch Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Transdermal Patch Distributors
13 Market Dynamics
13.1 Transdermal Patch Industry Trends
13.2 Transdermal Patch Market Drivers
13.3 Transdermal Patch Market Challenges
13.4 Transdermal Patch Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（通信回線）の最新刊レポート

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（transdermal patch）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/05　10:26

153.43 円

167.28 円

201.52 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.